Bayer aims to help CureVac with COVID-19 vaccine output, says CEO
BERLIN, Jan 17 (Reuters) – German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday. Though inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get......